Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy
-
Published:2024-09
Issue:
Volume:
Page:177001
-
ISSN:0014-2999
-
Container-title:European Journal of Pharmacology
-
language:en
-
Short-container-title:European Journal of Pharmacology
Author:
Ramadan Wafaa S.ORCID,
Alseksek Rahma K.,
Mouffak Soraya,
Talaat Iman M.ORCID,
Saber-Ayad Maha M.,
Menon Varsha,
Ilce Burcu Yener,
El-Awady RaafatORCID
Funder
University of Sharjah
Reference78 articles.
1. Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates;Acevedo;Mol Cell Biol,2003
2. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines;Alao;Clin Cancer Res,2004
3. Aldana-Masangkay, G.I., Sakamoto, K.M., 2011. The role of HDAC6 in cancer. J Biomed Biotechnol 2011, 875824.
4. HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation;Alothaim;Scientific Reports,2021
5. The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention;Alseksek;Int J Mol Sci,2022